Sally L. Glaser, Ph.D., Named CEO of the Northern California Cancer Center

Specialist in Hodgkin lymphoma to lead cancer prevention efforts at one of the
nation's largest prevention-focused cancer research centers

FREMONT, Calif., April 14 /PRNewswire-USNewswire/ -- Sally L. Glaser, Ph.D.,
a 19-year veteran at the Northern California Cancer Center (NCCC), has been
promoted to Chief Executive Officer of the organization, which is the only
center in the country conducting research dedicated solely to cancer
prevention. NCCC employs 135 staff members and has a $14 million operating
budget. Dr. Glaser, a research scientist, will continue to direct NCCC's
Greater Bay Area Cancer Registry, which collects cancer data for its
nine-county catchment area to better understand patterns of cancer occurrence,
treatment and survival. Previously, Dr. Glaser served as Director of
Surveillance Research at NCCC. She earned an A.B. from Harvard University and
an M.S. and Ph.D. in Epidemiology from the University of California, Berkeley.

"NCCC is positioned to be a critical partner in America's revitalized effort
to eradicate cancer," said Dr. Glaser, "I'm excited to lead our professional
team of researchers and numerous other staff members at the forefront of that
mission at NCCC."

NCCC is a nationally recognized leader in researching the causes of cancer and
improving cancer detection and prevention. The organization's programs, while
multifaceted, all address the inter-related aspects of cancer prevention.
Programs include the cancer registry, which tracks all cases for two of
California's ten cancer-reporting regions and aids NCCC in determining the
size of the problem of cancer occurrences and death. The organization also
conducts a wide variety of research studies, using data from the registry and
other sources to determine the causes of cancer and factors related to
survival after cancer. NCCC's distinctive outreach and community education
programs actively bring cancer prevention services to underserved and
low-income communities and improve the quality of life for individuals living
with cancer. NCCC's programs are also integral to the organization's
partnership with Stanford University and contribute to the university's
National Cancer Institute Cancer Center designation.

"We're extremely happy to have Dr. Glaser as CEO," said NCCC Chairman of the
Board Samuel Bronfman II. "Her scientific merits and experience combined with
her vision, enthusiasm, and ability to motivate others make her a perfect
choice for this position." Bronfman cited Dr. Glaser's research expertise,
management skills and passion for the work of NCCC scientists, registry staff,
and community educators, saying it has been "an asset to her leadership thus
far and will continue to inspire support for the cancer prevention cause."

The research that comes out of NCCC builds upon established knowledge bases
worldwide and contributes to the deepening understanding of how cancer affects
the entire population rather than only the individual patient. The
organization also examines what can be done to stop the spread of the disease.
NCCC works closely with regional, state, and national health departments
concerned with policy and health practice interventions in order to maximize
the health of individuals and families.

"Cancer surveillance is like an early warning system for the many diseases we
call 'cancer,'" said Dr. Glaser. "It tells us what's happening in the Greater
Bay Area and in the state -- not just in individual clinics. And while not
all cancer can yet be prevented, there is much more we can do to strengthen
California's response." Addressing areas in which NCCC will play a leading
role, Dr. Glaser cited ongoing research into the emerging causes of cancers,
community outreach, education efforts, and programs that promote screenings
for early detection when most cancers can easily be treated. The organization
is committed to conducting new research studies that point to interventions
that can stop cancer before it starts, and continues its leadership in state
outreach programs for low-income women.

About the Northern California Cancer Center:
Based in the San Francisco Bay Area city of Fremont, the Northern California
Cancer Center (NCCC) is an independent 501 (c) (3) non-profit organization
with a $14 million operating budget. It devotes its research efforts to
understanding who gets cancer and why, leading to more effective prevention.
NCCC was founded in 1974 by a consortium of the Stanford University and
University of California San Francisco medical schools, the California chapter
of the American Cancer Society, and community leaders. In 35 years of
operation, it has grown from its original role of assisting with clinical
trials of cancer drugs to serving as an asset to the nation's leading cancer
fighting organizations, including the National Institutes of Health and the
National Cancer Institute, scientists worldwide, educators, patients, and
clinicians. For more information, visit the Northern California Cancer
Center's website at www.nccc.org.

SOURCE Northern California Cancer Center

Serena Espinosa, External Affairs Associate, NCCC, +1-510-608-5160,
serena.espinosa@nccc.org; or Jo Ann Driscoll, Driscoll Public Relations &
Marketing, +1-510-663-1473 (office), +1-510-459-8144 (cell),
joannd@pacbell.net, for NCCC